Tirzepatide vs. Retatrutide: The Science Behind Dual and Triple-Agonist Metabolic Peptides
Tirzepatide and Retatrutide are redefining metabolic health with dual and triple-agonist pathways. Learn how these peptides target GLP-1, GIP, and glucagon receptors to drive unprecedented weight loss, improve insulin sensitivity, and boost energy expenditure.